These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2127064)

  • 1. [Study of anti-ischemic action of carnitine chloride and its effects on the effectiveness of antianginal agents].
    Tishkin VS; Dunaev VV; Kryzhanovskiĭ SA; Riabinin VA; Favoritov VN; Danilovich MI; Kacharava VG
    Kardiologiia; 1990 Oct; 30(10):89-91. PubMed ID: 2127064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The cardioprotective action of carnitine and its structural analog 3-(2,2,2-trimethylhydrazine)propionate on cardiac energy metabolism in experimental occlusion of the coronary artery in rats].
    Ratunova TM; Bauman VR; Kalvin'sh IIa
    Farmakol Toksikol; 1989; 52(5):24-7. PubMed ID: 2599072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of ischemic myocardium in experimental animals and in man: a review.
    Bolli R
    Cardiovasc Res Cent Bull; 1982; 21(1):1-33. PubMed ID: 6127160
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of carnitine on size limitation of experimental myocardial infarct.
    Ura K; Hironaka Y; Sakurai I
    Am J Cardiovasc Pathol; 1990; 3(2):131-42. PubMed ID: 2264986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardioprotective effect of carnitine and its synthetic analog 3-(2,2,2-trimethylhydrazinium) propionate in rats with experimental myocardial infarction].
    Ianson TM; Bauman VR; Grom NP; Kienkas IA; Kalvin'sh IIa
    Vopr Med Khim; 1988; 34(4):122-5. PubMed ID: 3195125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of metabolic therapy in myocardial infarct].
    Di Biase M; Biasco G; Rizzon P
    Cardiologia; 1991 Dec; 36(12 Suppl 1):389-92. PubMed ID: 1841795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of isoptin in the acute period of myocardial infarction (its effect on hemodynamics and myocardial metabolism)].
    Vakhliaev VD; Pomerantsev EV; Serova IV; Bogatyrev IV; Poltavskaia MG
    Kardiologiia; 1984 Oct; 24(10):60-3. PubMed ID: 6521184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-carnitine for the treatment of acute myocardial infarction.
    Dinicolantonio JJ; Niazi AK; McCarty MF; Lavie CJ; Liberopoulos E; O'Keefe JH
    Rev Cardiovasc Med; 2014; 15(1):52-62. PubMed ID: 24762466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of verapamil and nitroglycerin on experimental occlusion- reperfusion-induced myocardial infarction in rabbits].
    Shvilkin AV; Afonskaia NI; Sadretdinov SM; Cherpachenko NM; Levitskiĭ DO; Ruda MIa
    Kardiologiia; 1991 Jan; 31(1):15-7. PubMed ID: 1904510
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of antianginal preparations on the hemodynamics and metabolism of the ischemic myocardium].
    Makolkin VI; Vakhliaev VD
    Eksp Klin Farmakol; 1996; 59(4):18-20. PubMed ID: 9026181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New thoughts of pathophysiology and therapy of ischemic heart disease.
    Pepine CJ
    Cardiologia; 1991 Dec; 36(12 Suppl 1):373-7. PubMed ID: 1841793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of the ischemic myocardium by propionylcarnitine taurine amide. Comparison with other carnitine derivatives.
    Regitz V; Paulson DJ; Noonan J; Fleck E; Shug AL
    Z Kardiol; 1987; 76 Suppl 5():53-8. PubMed ID: 3433884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carnitine and solcoseryl in combined treatment of elderly and senile patients with myocardial infarction].
    Simonenko VB; Teslia AN
    Klin Med (Mosk); 1998; 76(1):42-5. PubMed ID: 9532916
    [No Abstract]   [Full Text] [Related]  

  • 15. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
    Liepinsh E; Makrecka M; Kuka J; Makarova E; Vilskersts R; Cirule H; Sevostjanovs E; Grinberga S; Pugovics O; Dambrova M
    Metabolism; 2014 Jan; 63(1):127-36. PubMed ID: 24140100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
    Asai T; Okumura K; Takahashi R; Matsui H; Numaguchi Y; Murakami H; Murakami R; Murohara T
    Cardiovasc Res; 2006 Jun; 70(3):566-77. PubMed ID: 16546150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid peroxidation in the myocardium in experimental infarct].
    Savov VM; Didenko VV; Dosmagambetova RS; Meerson FZ; Kagan VE
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (5):30-3. PubMed ID: 4027287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of verapamil for correcting the hemodynamic disorders in the acute period of a myocardial infarct].
    Molodan VI; Kopitsa NP; Dykun IaV; Zarivchatskaia IT
    Vrach Delo; 1990 Sep; (9):6-8. PubMed ID: 2126649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative evaluation of the effect of dimebon, obzidan, finoptin, and cordarone on the functional state of the ischemic focus and the size of necrosis zone during experimental myocardial infarction].
    Galenko-Iaroshevskiĭ PA; Melkumova ER; Bartashevich VV; Uvarov AV; Turovaia AIu; Khankoeva AI; Galygo DS
    Biull Eksp Biol Med; 1996 Dec; 122(12):642-4. PubMed ID: 9280462
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction of ischemic injury by nitroglycerin during acute myocardial infarction.
    Epstein SE; Kent KM; Goldstein RE; Borer JS; Redwood DR
    N Engl J Med; 1975 Jan; 292(1):29-35. PubMed ID: 803223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.